In Vivo Preclinical Evaluation of a Promising Antiarrhythmic Agent, EGIS-7229-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

In Vivo Preclinical Evaluation of a Promising Antiarrhythmic Agent, EGIS-7229

Published:2012-12-28 Issue:3 Volume:74 Page:173-185
ISSN:0272-4391
Container-title:Drug Development Research
language:en
Short-container-title:Drug Dev. Res.

Author:

Drimba László,Nemeth Jozsef,Sári Réka,Di Yin¹,Kovács Anikó²,Szénási Gábor²,Szilvássy Zoltán³,Peitl Barna

Affiliation:

1. Pharmapolis Debrecen Ltd; Nagyerdei Blvd. 98; H-4032; Debrecen; Hungary

2. Pharmacology Laboratory I; EGIS Pharmaceuticals PLC; 10, POB 100; H-1475; Budapest; Hungary

3. Department of Pharmacology and Pharmacotherapy; University of Debrecen Medical, Health, and Science Center; Nagyerdei Blvd. 98; H-4032; Debrecen; Hungary

Publisher

Wiley

Subject

Drug Discovery

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ddr.21058/fullpdf

Reference43 articles.

1. Dofetilide reduces the incidence of ventricular fibrillation during acute myocardial ischaemia. A randomised study in pigs;Andersen;Cardiovasc Res,1994

2. Pharmacology, pharmacodynamics and pharmacokinetics of sotalol;Antonaccio;Am J Cardiol,1990

3. EGIS-7229, the new combined class III antiarrhythmic agent: lack of EAD inducing effect;Banyasz;Gen Pharmacol,1999

4. An analysis of the time-relation of electrocardiogram;Bazett;Heart,1920

5. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial (CAMIAT): rationale and protocol. CAMIAT Investigators;Cairns;Am J Cardiol,1993

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP